Abstract
The effect of dofetilide on the steady-state pharmacokinetics of digoxin was evaluated in a randomized, double-blind study. Five days of dofetilide treatment did not significantly affect steady-state pharmacokinetic variables of digoxin compared with placebo; therefore, the use of dofetilide does not necessitate an adjustment in digoxin dose to maintain therapeutic digoxin levels.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Anti-Arrhythmia Agents / blood
-
Anti-Arrhythmia Agents / pharmacokinetics
-
Anti-Arrhythmia Agents / pharmacology*
-
Digoxin / blood
-
Digoxin / pharmacokinetics*
-
Digoxin / pharmacology
-
Double-Blind Method
-
Drug Interactions
-
Humans
-
Male
-
Phenethylamines / blood
-
Phenethylamines / pharmacology*
-
Sulfonamides / blood
-
Sulfonamides / pharmacology*
Substances
-
Anti-Arrhythmia Agents
-
Phenethylamines
-
Sulfonamides
-
Digoxin
-
dofetilide